Literature DB >> 9826752

The hyperthermophilic bacterium Thermotoga maritima has two different classes of family C DNA polymerases: evolutionary implications.

Y P Huang1, J Ito.   

Abstract

Bacterial DNA polymerase III (family C DNA polymerase), the principal chromosomal replicative enzyme, is known to occur in at least three distinct forms which have provisionally been classified as class I ( Escherichia coli DNA pol C-type), class II ( Bacillus subtilis DNA pol C-type) and class III (cyanobacteria DNA pol C-type). We have identified two family C DNA polymerase sequences in the hyperthermophilic bacterium Thermotoga maritima. One DNA polymerase consisting of 842 amino acid residues and having a molecular weight of 97 213 belongs to class I. The other one, consisting of 1367 amino acid residues and having a molecular weight of 155 361, is a member of class II. Comparative sequence analyses suggest that the class II DNA polymerase is the principal DNA replicative enzyme of the microbe and that the class I DNA polymerase may be functionally inactive. A phylogenetic analysis using the class II enzyme indicates that T.maritima is closely related to the low G+C Gram-positive bacteria, in particular to Clostridium acetobutylicum, and mycoplasmas. These results are in conflict with 16S rRNA-based phylogenies, which placed T.maritima as one of the deepest branches of the bacterial tree.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826752      PMCID: PMC147983          DOI: 10.1093/nar/26.23.5300

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  8 in total

1.  Robust incision of Benoz[a]pyrene-7,8-dihyrodiol-9,10-epoxide-DNA adducts by a recombinant thermoresistant interspecies combination UvrABC endonuclease system.

Authors:  Guo Hui Jiang; Milan Skorvaga; Deborah L Croteau; Bennett Van Houten; J Christopher States
Journal:  Biochemistry       Date:  2006-06-27       Impact factor: 3.162

2.  Inhibitors of DNA polymerase III as novel antimicrobial agents against gram-positive eubacteria.

Authors:  P M Tarantino; C Zhi; G E Wright; N C Brown
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

3.  Low frequencies of resistance among Staphylococcus and Enterococcus species to the bactericidal DNA polymerase inhibitor N(3)-hydroxybutyl 6-(3'-ethyl-4'-methylanilino) uracil.

Authors:  Michelle M Butler; Donna J Skow; Ryan O Stephenson; Patrick T Lyden; William A LaMarr; Kimberly A Foster
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  In vitro antimicrobial activities of novel anilinouracils which selectively inhibit DNA polymerase III of gram-positive bacteria.

Authors:  J S Daly; T J Giehl; N C Brown; C Zhi; G E Wright; R T Ellison
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

Review 5.  Whole-genome analysis of transporters in the plant pathogen Xylella fastidiosa.

Authors:  Joao Meidanis; Marilia D V Braga; Sergio Verjovski-Almeida
Journal:  Microbiol Mol Biol Rev       Date:  2002-06       Impact factor: 11.056

6.  Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.

Authors:  Michelle M Butler; William A Lamarr; Kimberly A Foster; Marjorie H Barnes; Donna J Skow; Patrick T Lyden; Lauren M Kustigian; Chengxin Zhi; Neal C Brown; George E Wright; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

7.  The fifth essential DNA polymerase phi in Saccharomyces cerevisiae is localized to the nucleolus and plays an important role in synthesis of rRNA.

Authors:  Kikuo Shimizu; Yasuo Kawasaki; Shin-Ichiro Hiraga; Maki Tawaramoto; Naomi Nakashima; Akio Sugino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

8.  A blueprint for a mutationist theory of replicative strand asymmetries formation.

Authors:  Vladislav V Khrustalev; Eugene V Barkovsky
Journal:  Curr Genomics       Date:  2012-03       Impact factor: 2.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.